6.1 Epidemiological and observational studies: a signal of prevention Several extensive observational studies, primarily utilizing real-world data from nationwide health registries and insurance claims databases, have provided compelling evidence that the use of GLP-1 receptor agonists is associated with a reduced risk of developing dementia
Information regarding clinical outcomes after a switch within the GLP-1 RA class is limited
Key hormones released by EECs include GLP-1, GIP, cholecystokinin (CCK), ghrelin, and peptide YY (PYY)
Interestingly, in individuals with HVDAS, the ADNP-SIRT1-EB1/EB3 protein complex may regulate autophagy, which is dysregulated and negatively affects mitochondrial metabolism in autism [344]
Treatment is monitored with regular lab work, and protocols are adjusted based on your response